MRPS9-AS1

Across TCGA pan-cancer cohorts, MRPS9-AS1 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of MRPS9-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MRPS9-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MRPS9-AS1 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

LIHC, LUAD, and COAD are the cancer types where MRPS9-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MRPS9-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	All	+0.245	<.001	8	view →
LUAD	Female	All	+0.502	<.001	6	view →
COAD	All	All	+0.271	.002	6	view →
CHOL	Male	All	+1.515	<.001	5	view →
BLCA	All	All	+0.379	.008	5	view →
STAD	All	II,III,IV	+0.374	.001	4	view →
LUSC	All	All	+0.332	.001	4	view →
KICH	All	All	−0.216	.013	4	view →
HNSC	All	II,III,IV	+0.209	.013	4	view →
KIRC	All	All	+0.195	.001	4	view →
READ	All	II,III,IV	+0.497	.017	2	view →
PRAD	All	All	+0.158	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

MRPS9-AS1–LIHC

Open the LIHC breakdown →